← Back to Analyst Consensus 
BTMD Buy
biote Corp.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 10, 2026 | B. Riley Securities | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 16, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Mar 12, 2026 | B. Riley Securities | maintain | Neutral → Neutral | — | 54% |
| Mar 12, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 7, 2025 | B. Riley Securities | downgrade | Buy → Neutral | $4 | 54% |
| Mar 13, 2025 | Craig-Hallum | maintain | Buy → Buy | $8 | 54% |
| Dec 16, 2024 | Craig-Hallum | initiate | — → Buy | $12 | 54% |
| Mar 13, 2024 | Roth MKM | reiterate | Buy → Buy | $9 | 52% |
| Feb 20, 2024 | B. Riley Securities | initiate | — → Buy | $9 | 54% |
| Feb 1, 2024 | Jefferies | initiate | — → Buy | $6.55 | 52% |
| Jan 18, 2024 | Truist Securities | maintain | Buy → Buy | $9 | 54% |
| Jan 18, 2024 | Roth MKM | maintain | Buy → Buy | $7 | 52% |
| Aug 15, 2023 | TD Cowen | maintain | Outperform → Outperform | $7 | 54% |
| Aug 14, 2023 | Roth MKM | reiterate | Buy → Buy | $12 | 52% |
| Mar 30, 2023 | Roth MKM | maintain | — → Buy | $11 | 52% |
| Sep 27, 2022 | Truist Securities | initiate | — → Buy | $10 | 54% |
| Jun 24, 2022 | Cowen & Co. | initiate | — → Outperform | $11 | — |
| Jun 23, 2022 | Roth Capital | initiate | — → Buy | $9 | 52% |
Price Target Trend
Apr 3, 2026 Oct 27, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days